Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg

Conditions:   Coronary Artery Disease;   Dyslipidemias Intervention:   Drug: a high dose of statin/ezetimib Sponsors:   Yonsei University;   dotter Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials